Aunt Minnie (10/3) reports, “A coalition of patient groups and breast cancer experts are appealing to the U.S. Congress to protect a mandate in the Affordable Care Act (ACA) that requires insurers to cover annual screening mammograms for women 40 and older.” AuntMinnie points out that the American College of Radiology us among “the patient groups backing the mandate.” In a statement, Dr. Debra Monticciolo, chair of the ACR’s breast imaging commission, said, “If Congress allows mandatory mammography insurance coverage to lapse for women 40 and older, many won’t be able to afford to get mammograms.” Dr. Monticciolo added, “Screening rates will drop. More women will die and the gains we have made against breast cancer may evaporate.”
Breast density reporting laws now exist in 28 states, but do women in those states know what, exactly, it means if an exam reveals they have dense breasts?
According to a recent study published in the Journal of the American College of Radiology, a majority of women in states with such laws do not know specific details about breast density and what it can mean for a woman’s health if she has dense breasts.
Medscape (9/29, O'Rourke) reports that “a retrospective study involving 4000 patients with ductal carcinoma in situ (DCIS) has demonstrated that a radiation boost after breast-conserving surgery plus whole-breast radiation therapy (WBRT) provides a clinically relevant reduction in local recurrence of 3.6% at 15 years.” The findings were presented at the American Society for Radiation Oncology 2016 Annual Meeting.
The management of breast lesions with uncertain malignant potential took center stage at the annual scientific meeting of the European Society of Breast Imaging, and breast imaging pioneer and SBI member Dr. Christiane Kuhl focused on MRI's impact on these questionable findings.
Aunt Minnie (9/28) reports that research suggests “a supplemental boost of radiation cuts breast cancer recurrence in women with ductal carcinoma in situ (DCIS) who receive whole-breast radiation therapy (WBRT) following lumpectomy.” The findings were presented at the American Society for Radiation Oncology conference.